Skip to main content


Health

Novartis says that it now seeks approval for serelaxin. Researchers say that in a study of 1,161 patients, the drug cut deaths from any cause at six months by 37 percent and led to a marked reduction in worsening of heart failure during hospitalization.
832 of 1819




Newsletter Sign Up



Daily Readings

Reading 1, First Thessalonians 4:1-8
Finally, brothers, we urge you and appeal to you in the Lord ... Read More

Psalm, Psalms 97:1, 2, 5-6, 10, 11-12
Yahweh is king! Let earth rejoice, the many isles be glad! ... Read More

Gospel, Matthew 25:1-13
'Then the kingdom of Heaven will be like this: Ten wedding ... Read More

Saint of the Day

August 28 Saint of the Day

St. Augustine of Hippo
August 28: St. Augustine of Hippo is the patron of brewers because of his ... Read More